Which has grown faster, BNTX or DXCM?

Over the past five years, BNTX grew revenue faster — BNTX at a 40.61% CAGR versus DXCM at 18.03%.

Is BNTX or DXCM more profitable?

DXCM runs the higher net margin — BNTX at -62.98% versus DXCM at 20.12%.

How have BNTX and DXCM total returns compared?

Over the past 5 years, BNTX delivered -19.46% and DXCM delivered 15.04% annualized total return. Past performance doesn't predict future results.

BioNTech SE (BNTX) vs DexCom, Inc. (DXCM)

A side-by-side comparison of BioNTech SE and DexCom, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 23, 2026. Differences are shown without an overall score or investment verdict.

BNTX

BioNTech SE

$29.28B

$116.57HealthcareAt close: Aug 21, 2026, 4:00 PM ET

DXCM

DexCom, Inc.

$34.85B

$92.34HealthcareAt close: Aug 21, 2026, 4:00 PM ET

Total return — BNTX vs DXCM

growth of $100 · dividends reinvested · last 7y

BNTX +729.5% (+35.3%/yr)DXCM +139.1% (+13.3%/yr)BNTX compounded faster over this window

BNTX DXCM

BNTX vs DXCM: by the numbers

•DXCM is the larger company ($34.85B vs $29.28B market cap).
•DXCM is profitable (20.12% net margin) while BNTX runs a net loss (-62.98%).
•BNTX grew revenue faster over the past five years (40.61% vs 18.03% CAGR).

Metrics side by side

Valuation

Metric	BNTX	DXCM
P/E ratio	N/A	36.50
Forward P/E	N/A	34.61
P/S ratio	9.53	7.28
P/B ratio	1.46	13.80
EV / EBITDA	N/A	25.99
FCF yield	2.10%	3.88%

Profitability

Metric	BNTX	DXCM
Gross margin	70.98%	62.47%
Operating margin	-22.63%	22.92%
Net margin	-62.98%	20.12%
ROE	-9.62%	38.14%
ROIC	-10.37%	21.71%

Growth (annualized)

Metric	BNTX	DXCM
Revenue CAGR (5Y)	40.61%	18.03%
EPS CAGR (5Y)	N/A	10.31%
FCF CAGR (5Y)	N/A	69.49%
Total return CAGR (5Y)	-19.46%	-6.57%

Frequently asked

Which has grown faster, BNTX or DXCM?: Over the past five years, BNTX grew revenue faster — BNTX at a 40.61% CAGR versus DXCM at 18.03%.
Is BNTX or DXCM more profitable?: DXCM runs the higher net margin — BNTX at -62.98% versus DXCM at 20.12%.
How have BNTX and DXCM total returns compared?: Over the past 5 years, BNTX delivered -19.46% and DXCM delivered 15.04% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BNTX analysis Full DXCM analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio BioNTech SE ROE DexCom ROE BioNTech SE operating margin DexCom operating margin BioNTech SE revenue growth DexCom revenue growth BioNTech SE free cash flow DexCom free cash flow

BioNTech SE & DexCom appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 23, 2026.